Chelsea Counsel Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,500
| Closed | -$425K | – | 83 |
|
|
2016
Q4 | $425K | Hold |
1,500
| – | – | 0.22% | 68 |
|
|
2016
Q3 | $470K | Sell |
1,500
-2,200
| -59% | -$689K | 0.24% | 62 |
|
|
2016
Q2 | $895K | Hold |
3,700
| – | – | 0.4% | 50 |
|
|
2016
Q1 | $963K | Hold |
3,700
| – | – | 0.31% | 56 |
|
|
2015
Q4 | $1.13M | Sell |
3,700
-1,100
| -23% | -$337K | 0.34% | 54 |
|
|
2015
Q3 | $1.4M | Buy |
4,800
+2,500
| +109% | +$730K | 0.33% | 54 |
|
|
2015
Q2 | $929K | Buy |
2,300
+300
| +15% | +$121K | 0.21% | 62 |
|
|
2015
Q1 | $844K | Sell |
2,000
-23
| -1% | -$9.71K | 0.18% | 63 |
|
|
2014
Q4 | $687K | Buy |
2,023
+1,000
| +98% | +$340K | 0.14% | 68 |
|
|
2014
Q3 | $338K | Sell |
1,023
-600
| -37% | -$198K | 0.07% | 98 |
|
|
2014
Q2 | $512K | Buy |
+1,623
| New | +$512K | 0.1% | 80 |
|
|
2014
Q1 | – | Sell |
-1,023
| Closed | -$286K | – | 124 |
|
|
2013
Q4 | $286K | Hold |
1,023
| – | – | 0.07% | 87 |
|
|
2013
Q3 | $246K | Sell |
1,023
-800
| -44% | -$192K | 0.05% | 100 |
|
|
2013
Q2 | $392K | Buy |
+1,823
| New | +$392K | 0.1% | 70 |
|